Prognosis of autoimmune hepatitis showing acute presentation. Issue 6 (22nd October 2012)
- Record Type:
- Journal Article
- Title:
- Prognosis of autoimmune hepatitis showing acute presentation. Issue 6 (22nd October 2012)
- Main Title:
- Prognosis of autoimmune hepatitis showing acute presentation
- Authors:
- Yamamoto, Kazuhide
Miyake, Yasuhiro
Ohira, Hiromasa
Suzuki, Yoshiyuki
Zeniya, Mikio
Onji, Morikazu
Tsubouchi, Hirohito - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="hepr1109-sec-0001" sec-type="section"> <title>Aim</title> <p>The number of patients with autoimmune hepatitis (AIH) showing acute presentation has increased. This study aimed to assess their prognosis.</p> </sec> <sec id="hepr1109-sec-0002" sec-type="section"> <title>Methods</title> <p>A survey of AIH patients by sending questionnaires was performed, and 96 patients showing acute presentation were investigated.</p> </sec> <sec id="hepr1109-sec-0003" sec-type="section"> <title>Results</title> <p>The median age was 58 years and 78 patients (81%) were female. Eighty‐four patients (88%) were positive for antinuclear antibody and/or anti‐smooth muscle antibody. The median serum immunoglobulin G level was 2252 mg/dL. Twenty‐five patients (26%) showed histological acute hepatitis. As initial treatment, 88 patients (92%) were treated with corticosteroid, and 28 of them received pulse steroid treatment. Overall, 11 patients (11%) reached fatal outcomes (nine death and two liver transplantation). Patients with histological acute hepatitis showed higher serum bilirubin levels, lower prothrombin activities and higher prothrombin time–international normalized ratios (PT‐INR) and reached fatal outcomes more frequently. With a multivariate logistic regression analysis, prothrombin activity and PT‐INR at presentation was associated with fatal outcomes. Nine of 13 patients (69%) showing prothrombin<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <sec id="hepr1109-sec-0001" sec-type="section"> <title>Aim</title> <p>The number of patients with autoimmune hepatitis (AIH) showing acute presentation has increased. This study aimed to assess their prognosis.</p> </sec> <sec id="hepr1109-sec-0002" sec-type="section"> <title>Methods</title> <p>A survey of AIH patients by sending questionnaires was performed, and 96 patients showing acute presentation were investigated.</p> </sec> <sec id="hepr1109-sec-0003" sec-type="section"> <title>Results</title> <p>The median age was 58 years and 78 patients (81%) were female. Eighty‐four patients (88%) were positive for antinuclear antibody and/or anti‐smooth muscle antibody. The median serum immunoglobulin G level was 2252 mg/dL. Twenty‐five patients (26%) showed histological acute hepatitis. As initial treatment, 88 patients (92%) were treated with corticosteroid, and 28 of them received pulse steroid treatment. Overall, 11 patients (11%) reached fatal outcomes (nine death and two liver transplantation). Patients with histological acute hepatitis showed higher serum bilirubin levels, lower prothrombin activities and higher prothrombin time–international normalized ratios (PT‐INR) and reached fatal outcomes more frequently. With a multivariate logistic regression analysis, prothrombin activity and PT‐INR at presentation was associated with fatal outcomes. Nine of 13 patients (69%) showing prothrombin activity of 40% or lower at presentation and nine of 19 patients (47%) showing PT‐INR of 1.5 or higher reached fatal outcomes. Furthermore, of 13 patients showing prothrombin activity of 40% or lower and/or PT‐INR of 1.5 or higher at presentation who were treated with pulse steroid treatment, four (31%) died from infectious disease.<xref ref-type="link" rid="hepr1109-note-9001">1</xref></p> </sec> <sec id="hepr1109-sec-0004" sec-type="section"> <title>Conclusion</title> <p>Prothrombin activity and PT‐INR are prognostic factors for AIH showing acute presentation. Physicians should pay attention to the development of infectious disease when pulse steroid treatment is performed.<xref ref-type="link" rid="hepr1109-note-9001">1</xref></p> </sec> </abstract> … (more)
- Is Part Of:
- Hepatology research. Volume 43:Issue 6(2013:Jun.)
- Journal:
- Hepatology research
- Issue:
- Volume 43:Issue 6(2013:Jun.)
- Issue Display:
- Volume 43, Issue 6 (2013)
- Year:
- 2013
- Volume:
- 43
- Issue:
- 6
- Issue Sort Value:
- 2013-0043-0006-0000
- Page Start:
- 630
- Page End:
- 638
- Publication Date:
- 2012-10-22
- Subjects:
- Liver -- Diseases -- Periodicals
Liver Diseases -- Periodicals
Foie -- Maladies -- Périodiques
616.362 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09284346 ↗
http://firstsearch.oclc.org/journal=1386-6346;screen=info;ECOIP ↗
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1872-034X ↗
http://www.sciencedirect.com/science/journal/13866346 ↗
http://www3.interscience.wiley.com/journal/118507311/home ↗
http://www.blackwell-synergy.com/rd.asp?goto=journal&code=hep ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/j.1872-034X.2012.01109.x ↗
- Languages:
- English
- ISSNs:
- 1386-6346
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4295.845000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3360.xml